Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 31-May-24 5:51 PM View:  | Arvinas, Inc. (ARVN) | 29-May-24 | Grant | 5,899 | -- | -- | 24% 24.1K to 30.0K | |
| 09-Feb-24 4:04 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 07-Feb-24 | Grant | 17,000 | -- | -- | 95% 17.84K to 34.84K | |
| 10-Aug-23 6:50 AM View: | Syndax Pharmaceuticals Inc (SNDX) | 09-Aug-23 | Option Exercise | 52,855 | $8.77 | $463,538.00 | 296% 17.84K to 70.69K | |
| 10-Aug-23 6:50 AM View: | Syndax Pharmaceuticals Inc (SNDX) | 09-Aug-23 | Option Sale | 52,855 | $18.27 | $965,402.00 | (75%) 70.69K to 17.84K | |
| 11-Jul-23 9:23 AM View: | Syndax Pharmaceuticals Inc (SNDX) | 10-Jul-23 | Option Exercise | 52,855 | $8.77 | $463,538.00 | 296% 17.84K to 70.69K | |
| 11-Jul-23 9:23 AM View: | Syndax Pharmaceuticals Inc (SNDX) | 10-Jul-23 | Option Sale | 52,855 | $20.40 | $1,078,070.00 | (75%) 70.69K to 17.84K | |
| 09-Jun-23 5:32 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 09-Jun-23 | Option Exercise | 52,855 | $7.66 | $404,787.00 | 296% 17.84K to 70.69K | |
| 09-Jun-23 5:32 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 09-Jun-23 | Option Sale | 52,855 | $21.18 | $1,119,420.00 | (75%) 70.69K to 17.84K | |
| 10-May-23 4:11 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 09-May-23 | Option Exercise | 52,855 | $6.38 | $337,215.00 | 296% 17.84K to 70.69K | |
| 10-May-23 4:11 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 09-May-23 | Option Sale | 52,855 | $21.41 | $1,131,480.00 | (75%) 70.69K to 17.84K | |
| 12-Apr-23 4:03 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 10-Apr-23 | Option Exercise | 52,855 | $6.38 | $337,215.00 | 296% 17.84K to 70.69K | |
| 12-Apr-23 4:03 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 10-Apr-23 | Option Sale | 52,855 | $19.53 | $1,032,240.00 | (75%) 70.69K to 17.84K | |
| 14-Mar-23 4:42 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 13-Mar-23 | Option Exercise | 52,854 | $6.38 | $337,209.00 | 296% 17.84K to 70.69K | |
| 14-Mar-23 4:42 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 13-Mar-23 | Planned Option Sale | 52,854 | $22.53 | $1,190,670.00 | (75%) 70.69K to 17.84K | |
| 09-Mar-23 10:00 PM View: | Carisma Therapeutics Inc. (CARM) | 07-Mar-23 | Grant | 12,175 | -- | -- | 100% 0 to 12.18K | |
| 08-Feb-23 4:49 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 06-Feb-23 | Option Exercise | 52,854 | $6.38 | $337,209.00 | 296% 17.84K to 70.69K | |
| 08-Feb-23 4:49 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 06-Feb-23 | Planned Option Sale | 52,854 | $26.83 | $1,417,910.00 | (75%) 70.69K to 17.84K | |
| 21-Sep-22 4:18 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 20-Sep-22 | Option Exercise | 59,649 | $10.90 | $650,174.00 | 334% 17.84K to 77.48K | |
| 21-Sep-22 4:18 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 20-Sep-22 | Planned Option Sale | 59,649 | $23.25 | $1,387,010.00 | (77%) 77.48K to 17.84K | |
| 21-Sep-22 4:18 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 19-Sep-22 | Option Exercise | 114,339 | $10.90 | $1,246,300.00 | 641% 17.84K to 132.18K | |
| 21-Sep-22 4:18 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 19-Sep-22 | Planned Option Sale | 114,339 | $23.03 | $2,633,040.00 | (87%) 132.18K to 17.84K | |
| 16-Sep-22 5:34 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 16-Sep-22 | Option Exercise | 125,000 | $8.77 | $1,096,230.00 | 701% 17.84K to 142.84K | |
| 16-Sep-22 5:34 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 16-Sep-22 | Planned Option Sale | 125,000 | $23.22 | $2,902,440.00 | (88%) 142.84K to 17.84K | |
| 16-Sep-22 5:34 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 15-Sep-22 | Option Exercise | 66,775 | $7.20 | $480,780.00 | 374% 17.84K to 84.61K | |
| 16-Sep-22 5:34 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 15-Sep-22 | Planned Option Sale | 66,775 | $24.20 | $1,616,040.00 | (79%) 84.61K to 17.84K | |
| 16-Sep-22 5:34 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 14-Sep-22 | Option Exercise | 87,645 | $7.20 | $631,044.00 | 491% 17.84K to 105.48K | |
| 16-Sep-22 5:34 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 14-Sep-22 | Planned Option Sale | 87,645 | $23.80 | $2,085,850.00 | (83%) 105.48K to 17.84K | |
| 05-Jul-22 4:09 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 01-Jul-22 | Option Exercise | 62,292 | $7.20 | $448,502.00 | 349% 17.84K to 80.13K | |
| 05-Jul-22 4:09 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 01-Jul-22 | Planned Option Sale | 62,292 | $19.00 | $1,183,430.00 | (78%) 80.13K to 17.84K | |
| 18-Apr-22 9:00 PM View: | Arvinas, Inc. (ARVN) | 14-Apr-22 | Option Exercise | 16,188 | $16.00 | $259,008.00 | 65% 24.75K to 40.94K | |
| 18-Apr-22 9:00 PM View: | Arvinas, Inc. (ARVN) | 14-Apr-22 | Planned Option Sale | 16,188 | $66.44 | $1,075,560.00 | (40%) 40.94K to 24.75K | |
| 18-Apr-22 9:00 PM View: | Arvinas, Inc. (ARVN) | 14-Apr-22 | Sale (Planned) | 4,772 | $66.44 | $317,059.00 | (19%) 24.75K to 19.98K | |
| 05-Apr-22 4:05 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 04-Apr-22 | Option Exercise | 3,128 | $10.90 | $34,095.20 | 18% 17.84K to 20.96K | |
| 05-Apr-22 4:05 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 04-Apr-22 | Sale (Planned) | 3,128 | $18.29 | $57,219.90 | (15%) 20.96K to 17.84K | |
| 05-Apr-22 4:05 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 01-Apr-22 | Option Exercise | 70,545 | $10.90 | $768,940.00 | 146% 48.34K to 118.88K | |
| 05-Apr-22 4:05 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 01-Apr-22 | Planned Option Sale | 73,673 | $17.45 | $1,285,800.00 | (62%) 118.88K to 45.21K | |
| 05-Apr-22 4:05 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 01-Apr-22 | Sale (Planned) | 27,372 | $17.45 | $477,717.00 | (61%) 45.21K to 17.84K | |
| 19-Jan-22 9:00 PM View: | Arvinas, Inc. (ARVN) | 14-Jan-22 | Option Exercise | 16,188 | $16.00 | $259,008.00 | 55% 29.52K to 45.71K | |
| 19-Jan-22 9:00 PM View: | Arvinas, Inc. (ARVN) | 14-Jan-22 | Planned Option Sale | 16,188 | $65.55 | $1,061,190.00 | (35%) 45.71K to 29.52K | |
| 19-Jan-22 9:00 PM View: | Arvinas, Inc. (ARVN) | 14-Jan-22 | Sale (Planned) | 4,772 | $65.55 | $312,826.00 | (16%) 29.52K to 24.75K | |
| 20-Dec-21 6:44 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 17-Dec-21 | Option Exercise | 35,156 | $10.90 | $383,200.00 | 73% 48.34K to 83.49K | |
| 20-Dec-21 6:44 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 17-Dec-21 | Market Option Sale (Planned) | 35,156 | $20.00 | $703,120.00 | (42%) 83.49K to 48.34K | |
| 21-Sep-21 10:00 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 20-Sep-21 | Option Exercise | 50 | $7.20 | $360.00 | < 1% 48.34K to 48.39K | |
| 21-Sep-21 10:00 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 20-Sep-21 | Market Option Sale (Planned) | 50 | $20.00 | $1,000.00 | (< 1%) 48.39K to 48.34K | |
| 21-Sep-21 10:00 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 17-Sep-21 | Option Exercise | 70,262 | $7.20 | $505,886.00 | 145% 48.34K to 118.6K | |
| 21-Sep-21 10:00 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 17-Sep-21 | Market Option Sale (Planned) | 70,262 | $20.07 | $1,410,020.00 | (59%) 118.6K to 48.34K | |
| 17-Feb-21 6:05 PM View: | Codiak Biosciences, Inc. (CDAK) | 17-Feb-21 | Market Purchase | 4,761 | $21.00 | $99,981.00 | 100% 0 to 4.76K | |
| 10-Feb-21 4:23 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 08-Feb-21 | Option Exercise | 35,156 | $7.20 | $253,123.00 | 73% 48.34K to 83.49K | |
| 10-Feb-21 4:23 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 08-Feb-21 | Market Option Sale (Planned) | 35,156 | $20.55 | $722,403.00 | (42%) 83.49K to 48.34K | |
| 05-Feb-21 4:21 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 31-Jan-21 | Acquisition (other) | 1,771 | $12.00 | $21,252.00 | 4% 46.56K to 48.34K |